ARB-272572

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameARB-272572
Drug Alias NameARB-272572
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed cell death protein 1 blockersProgrammed death-ligand 1 blockers
TargetsProgrammed cell death protein 1Programmed death-ligand 1
Therapy Area/IndicationsImmune System DiseasesNeoplasmsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArbutus Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesArbutus Biopharma Inc
Inactive CompaniesN/A
Active IndicationsImmune System DiseasesNeoplasmsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A